Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients?
…, K Ozierański, M Zaleska, K Żukowska… - Cardiology …, 2020 - journals.viamedica.pl
… records of AF patients treated with vitamin K antagonists (VKAs… (apixaban) may reflect on
real-life clinical practice. The aim … ban in a German community [20]. In this study risk of stroke in …
real-life clinical practice. The aim … ban in a German community [20]. In this study risk of stroke in …
Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients
E Freisinger, J Gerß, L Makowski… - European Heart …, 2020 - academic.oup.com
… the annual prescription of vitamin K antagonists (VKAs) and … or supra-therapeutic NOAC
levels, not detected in routine practice. In … The majority of VKA-treated patients in Germany and …
levels, not detected in routine practice. In … The majority of VKA-treated patients in Germany and …
Non–Vitamin K Antagonist Oral Anticoagulants and Factors Influencing the Ischemic and Bleeding Risk in Elderly Patients With Atrial Fibrillation: A Review of Current …
G Patti, S Haas - Journal of Cardiovascular Pharmacology, 2021 - journals.lww.com
… In this study, apixaban treatment resulted in decreased major … seen in studies of routine
clinical practice. This is despite … , Germany, and the United Kingdom, examined AF patient …
clinical practice. This is despite … , Germany, and the United Kingdom, examined AF patient …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
…, R Bavalia, H Xiong, KM van de Wiel, K Mulder… - TH Open, 2023 - thieme-connect.com
… over vitamin K antagonists (VKAs) as anticoagulant treatment … assess therapy nonadherence
in daily clinical practice within a … Adherence to rivaroxaban, dabigatran, and apixaban for …
in daily clinical practice within a … Adherence to rivaroxaban, dabigatran, and apixaban for …
[PDF][PDF] … of oral anticoagulants prescribing for atrial fibrillation in general practice: a study based on routine practice data from general practices in the Netherlands
…, M Horsselenberg, JC Korevaar, C Wagner, K Hek - BJGP Open, 2023 - bjgpopen.org
… Non- vitamin K antagonist oral anticoagulation usage according to age among patients with
atrial fibrillation: … Good quality of oral anticoagulation treatment in general practice using …
atrial fibrillation: … Good quality of oral anticoagulation treatment in general practice using …
… persistence with once-daily vs twice-daily direct oral anticoagulants among patients with atrial fibrillation: real-world analyses from the Netherlands, Italy and Germany
E Smits, F Andreotti, E Houben, HJGM Crijns… - Drugs-Real World …, 2022 - Springer
… Non-valvular atrial fibrillation (AF) is the most common … by antithrombotic therapy,
specifically vitamin K antagonists (… ; in Germany, it was apixaban (63%); in Italy, apixaban and …
specifically vitamin K antagonists (… ; in Germany, it was apixaban (63%); in Italy, apixaban and …
Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary …
W Bachorski, J Bychowski, M Gruchała, M Jaguszewski - Diagnostics, 2023 - mdpi.com
… with vitamin K antagonists (VKA) or non-vitamin K antagonist … bleeding occurred in the group
who received apixaban. … that VKA treatment is still popular in clinical practice mainly due to …
who received apixaban. … that VKA treatment is still popular in clinical practice mainly due to …
Safety and efficacy of oral anticoagulants therapies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis
… Different antithrombotic treatments, from vitamin K antagonists to … comparing the efficacy of
apixaban versus warfarin in … for their use in clinical practice. Additionally, real-world studies, …
apixaban versus warfarin in … for their use in clinical practice. Additionally, real-world studies, …
Retrospective study of etiology and treatment outcomes of patients with gastrointestinal bleedings with focus on exposure to vitamin K antagonists and new oral …
I Smirnov - 2024 - refubium.fu-berlin.de
… rivaroxaban (Xarelto®), apixaban (Eliquis®), and edoxaban (… NOAC-treated patients in a
community practice setting … may facilitate the endoscopic treatment [29], German Society for …
community practice setting … may facilitate the endoscopic treatment [29], German Society for …
Use of non-vitamin K antagonist oral anticoagulants for stroke prevention across the stroke spectrum: progress and prospects
AJ Camm, D Atar - Thrombosis and Haemostasis, 2021 - thieme-connect.com
… in the majority of patients with atrial fibrillation (AF). However, … demonstrated that the relative
efficacy and safety of NOACs … analysis using German claims data, rivaroxaban, apixaban, …
efficacy and safety of NOACs … analysis using German claims data, rivaroxaban, apixaban, …